There has been a massive acceleration of digitally driven innovation in our lives as of late and the life sciences industry is of course no exception.
There is a huge unmet need in treating patients with brain diseases; clinical trials fail and finding effective therapies is hard.
ANNOUNCING LEADERSHIP CHANGES AT QMENTA – NEW CEO APPOINTED AND...
MARTINOS CENTER FOR BIOMEDICAL IMAGING, UNIVERSITY OF ROCHESTER, AND QMENTA...
Medical imaging in clinical trials reduces costs and improves time to market, but many biopharma companies leave these benefits on the table.
QMENTA’s AI Platform Selected for the CAVS-MS Multiple Sclerosis Biomarker...
UK neurologists publish details of mildly affected or recovering Covid-19...
Contrast-enhanced ultrasound scans revealed patterns in the lung not typically...
Quantitative computer-aided analysis of chest CT (QCT) scans can help...